Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2016 1
2018 2
2019 2
2020 2
2021 5
2022 2
2024 2
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum.
[No authors listed] [No authors listed] Am J Sports Med. 2016 Nov;44(11):NP68. doi: 10.1177/0363546516676467. Am J Sports Med. 2016. PMID: 28036227
Jagodzinski M, Behfar V, Hurschler C, Albrecht K, Krettek C, Bosch U. Femoral press-fit fixation of the hamstring tendons for anterior cruciate ligament reconstruction. ...
Jagodzinski M, Behfar V, Hurschler C, Albrecht K, Krettek C, Bosch U. Femoral press-fit fixation of the hamstring tendons for …
M(3)RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction.
Singh RD, Hillestad ML, Livia C, Li M, Alekseev AE, Witt TA, Stalboerger PG, Yamada S, Terzic A, Behfar A. Singh RD, et al. Tissue Eng Part A. 2019 Jan;25(1-2):145-158. doi: 10.1089/ten.TEA.2017.0445. Epub 2018 Sep 21. Tissue Eng Part A. 2019. PMID: 30047313 Free PMC article.
The M(3)RNA (microencapsulated modified messenger RNA) platform is an approach to deliver messenger RNA (mRNA) in vivo, achieving a nonintegrating and viral-free approach to gene therapy. ...By testing the technology in large animal models of infarction, compatibility of …
The M(3)RNA (microencapsulated modified messenger RNA) platform is an approach to deliver messenger RNA (mRNA) in vivo, achieving a n …
Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
Behfar M, Koochakzadeh L, Yazdanian N, Salajegheh P, Rostami T, Khodayari-Namini N, Ghavamzadeh A, Hamidieh AA. Behfar M, et al. Turk J Pediatr. 2019;61(3):407-412. doi: 10.24953/turkjped.2019.03.013. Turk J Pediatr. 2019. PMID: 31916719 Free article.
Behfar M, Koochakzadeh L, Yazdanian N, Salajegheh P, Rostami T, Khodayari-Namini N, Ghavamzadeh A, Hamidieh AA. ...
Behfar M, Koochakzadeh L, Yazdanian N, Salajegheh P, Rostami T, Khodayari-Namini N, Ghavamzadeh A, Hamidieh AA. ...
Brachyury engineers cardiac repair competent stem cells.
Li M, Yamada S, Shi A, Singh RD, Rolland TJ, Jeon R, Lopez N, Shelerud L, Terzic A, Behfar A. Li M, et al. Stem Cells Transl Med. 2021 Mar;10(3):385-397. doi: 10.1002/sctm.20-0193. Epub 2020 Oct 24. Stem Cells Transl Med. 2021. PMID: 33098750 Free PMC article.
To this end, the microencapsulated-modified-mRNA (M(3) RNA) technique was here applied to introduce early cardiogenic genes into human adipose-derived mesenchymal stem cells (AMSCs). ...
To this end, the microencapsulated-modified-mRNA (M(3) RNA) technique was here applied to introduce early cardiogenic genes into huma …
[89Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure.
Bansal A, Pandey MK, Yamada S, Goyal R, Schmit NR, Jeon R, Nesbitt JJ, Witt TA, Singh RD, Gunderson TM, Boroumand S, Li M, Crespo-Diaz RJ, Hillestad ML, Terzic A, Behfar A, DeGrado TR. Bansal A, et al. Nucl Med Biol. 2020 Nov-Dec;90-91:23-30. doi: 10.1016/j.nucmedbio.2020.09.001. Epub 2020 Sep 9. Nucl Med Biol. 2020. PMID: 32957056 Free PMC article.
Optimal Hemodynamics and Risk of Severe Outcomes Post-Left Ventricular Assist Device Implantation.
Rosenbaum AN, Ternus BW, Stulak JM, Clavell AL, Schettle SD, Behfar A, Jentzer JC. Rosenbaum AN, et al. ASAIO J. 2022 Mar 1;68(3):325-332. doi: 10.1097/MAT.0000000000001465. ASAIO J. 2022. PMID: 35213881
Optimal dichotomization points were 500 mmHg*ml*m-2, 12 mmHg, and 40 mg/dL. The three-component model identified an AUC of 0.77 (p < 0.0001) for the composite endpoint. ...
Optimal dichotomization points were 500 mmHg*ml*m-2, 12 mmHg, and 40 mg/dL. The three-component model identified an AUC of 0.77 (p &l …
18 results